D-0498-2024 Class II Ongoing

Recalled by MACLEODS PHARMA USA, INC — Princeton, NJ

FDA drug recall D-0498-2024 was initiated by MACLEODS PHARMA USA, INC on May 7, 2024 and is designated Class II. Reason for recall: Presence of foreign substance: plastic-like substance. The recall status is ongoing. Affected quantity: 1,048 bottles.

Recall details

Product Type
Drugs
Report Date
May 22, 2024
Initiation Date
May 7, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,048 bottles

Product description

Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-050-44

Reason for recall

Presence of foreign substance: plastic-like substance.

Distribution pattern

USA Nationwide

Code information

Lot #: BLK2304A, Exp. 07/31/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0498-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0498-2024. Report a data issue: hello@regdatalab.com.